S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells

https://doi.org/10.1016/j.molimm.2015.05.014Get rights and content

Highlights

  • S100A9-induced release of IL-6 and IL-8 from PDL cells depends on TLR4.

  • S100A9 up-regulates the secretion of IL-6 through NF-κB and p38 pathways.

  • S100A9 up-regulates IL-8 through the NF-κB, ERK1/2, JNK and p38 pathways.

  • S100A9-mediated secretion of IL-6, IL-8 depends on ROS production.

Abstract

S100A8, S100A9, and calprotectin (the S100A8/S100A9 complex) are calcium-binding proteins that promote extracellular pro-inflammatory functions and may play an important role in periodontal disease. Both toll-like receptor 4 (TLR4) and the receptor for advanced glycation end-products (RAGE) are thought to be important receptors for S100A8, S100A9, and calprotectin, but the specific pathways in periodontal ligament (PDL) cells are not yet clear. Our study was designed to identify the specific receptors for S100A9 in human PDL cells. Additionally, we investigated the specific pathways that activate the secretion of pro-inflammatory cytokines interleukins (IL)-6 and IL-8 in PDL cells. The role of nuclear factor (NF)-κB, mitogen-activated protein kinase (MAPK) and reactive oxygen species (ROS) in S100A9-induced pro-inflammatory cytokines were investigated through western blot analysis, dichlorodihydrofluorescein diacetate (H2DCFDA) probe and the application of specific pathway inhibitors. Our results suggest that the S100A9-induced release of IL-6 and IL-8 from human PDL cells is dependent on TLR4, but not RAGE. We provide evidence that S100A9 promotes the secretion of IL-6 and IL-8 through different pathways. Specifically, S100A9 up-regulates the secretion of IL-6 from human PDL cells through NF-κB and p38 pathways and up-regulates the release of IL-8 from human PDL cells through the NF-κB, extracellular-regulated kinase (ERK) 1/2, c-Jun amino-terminal kinase (JNK) 1/2, and p38 signaling pathways. In addition, the release of both cytokines depends on ROS production. The release of both cytokines depends on ROS production. These results suggest that S100A9 promotes pro-inflammatory responses in PDL cells through the TLR4-mediated NF-κB and MAPK signaling pathways.

Introduction

Periodontitis is a chronic inflammatory disease of the tooth-supporting tissues that is characterized by alveolar bone loss (Cochran, 2008, Di Benedetto et al., 2013). The role of bacterial infection in the etiology of periodontitis is well supported (Hernandez et al., 2011), but the role of the host immune response is not fully understood. It is possible that the activation of the host inflammatory and immune responses may also contribute to the destruction of periodontal tissues (Cochran, 2008, Di Benedetto et al., 2013). Periodontal ligament (PDL) links teeth to alveolar bone and participates in alveolar bone remodeling. PDL cells reside in PDL space, characterized by the production of collagen fibers and mineralized tissue (Jonsson et al., 2011). Pattern recognition receptors (PRRs) on the resident cells of the periodontium play an important role in the innate immune response by recognizing bacteria-derived factors and promoting the production of cytokines and chemokines, which are key mediators of inflammation and bone loss (Cochran, 2008, Di Benedetto et al., 2013).

S100A8 and S100A9 are calcium-binding proteins that have been identified as important endogenous damage-associated molecular patterns (DAMP) or alarmins (Schiopu and Cotoi, 2013). S100A8 and S100A9 are recognized by PRRs and promote extracellular pro-inflammatory functions (Schiopu and Cotoi, 2013). S100A8 and S100A9 exist as non-covalently bonded homodimers, but S100A8 and S100A9 form the non-covalent heterodimer calprotectin (or the S100A8/A9 complex) in the presence of calcium (Simard et al., 2013).

Due to their pro-inflammatory functions, S100A8, S100A9, and calprotectin are associated with numerous autoimmune and inflammatory diseases, including arthritis (Foell et al., 2007), systemic lupus erythematous (Bjork et al., 2009), Crohn's disease (Lugering et al., 1995), periodontitis (Meng et al., 2002, Kojima et al., 2000), as well as other various diseases (Kallberg et al., 2012, Cesaro et al., 2012, Ichikawa et al., 2011, Boyd et al., 2008). The levels of calprotectin in gingival crevicular fluid and serum are increased in patients with periodontitis and decreased following periodontal treatment; therefore, calprotectin may be used as a biomarker to diagnose periodontitis and to monitor the response to periodontal treatment (Kido et al., 1999, Andersen et al., 2010).

S100A8, S100A9, and calprotectin are clearly related to periodontal disease but the pathological roles of these proteins have not been investigated thoroughly. Certain periodontal pathogens, such as porphyromonas gingivalis lipopolysaccharide, may promote the release of calprotectin from neutrophils and monocytes (Kido et al., 2004, Suryono et al., 2003, Kido et al., 2005), but the mechanisms of calprotectin release from neutrophils and monocytes have yet to be elucidated. Furthermore, S100A8 and S100A9 may also play distinct roles in the onset of periodontal disease. For instance, Nishii et al. (2013) reported the expression of S100A9 was significantly increased at the presence of microflora, while S100A8 protein expression was not affected by bacterial infection.

The main receptors for S100A8, S100A9, and calprotectin are toll-like receptor 4 (TLR4) and the receptor for advanced glycation end-products (RAGE), but the specific receptors and pathways for S100A8, S100A9, and calprotectin depend on different cell types. For instance, S100A9 triggers nuclear factor (NF)-κB responses via TLR4 in THP-1 cells (Riva et al., 2012) and triggers NF-κB and extracellular-regulated kinase (ERK) 1/2 mitogen-activated protein kinase (MAPK) responses via RAGE in lung fibroblast cells (Xu et al., 2013), whereas S100A8, S100A9, and calprotectin triggers MAPKs responses via TLR4 and RAGE in endothelial cells (Wang et al., 2014).

Our previous study reported that calprotectin promotes pro-inflammatory responses in PDL cells via the S100A9 subunit (Zheng et al., 2014), but no published studies have investigated the potential receptor and signaling pathways engaged by S100A9 in human PDL cells. We hypothesized that S100A9 induces the production of IL-6 and IL-8 from human PDL cells through NF-κB and MAPKs signaling pathways mediated by TLR4.

Section snippets

Ethics statement

This study was approved by the Ethics Committee of Peking University School of Stomatology (Approval number PKUSSIRB-2011007). Participants and/or their guardians provided written informed consent before participating in this study.

Reagents

Human recombinant S100A9 were produced as previously described by Ryckman et al. (2003) and were found to contain less than 1 pg endotoxin/μg of protein measured by Limulus amebocyte assay (Sigma–Aldrich, St. Louis, MO). The RAGE blocking antibody was from R&D systems

S100A9 promoted secretion of IL-6 and IL-8 from human PDL cells in a dose- and time-dependent manner

We previously reported that S100A9 but not S100A8 promoted the release of IL-6, IL-8 from PDL cells (Zheng et al., 2014). To confirm the effect of S100A9 on the production of IL-6 and IL-8, human PDL cells were treated by S100A9 with concentrations of 1, 10, and 100 μg/mL. As expected, the mRNA levels of IL-6 and IL-8 were increased in a dose-dependent manner (Fig. 1A and B). ELISA results further confirmed the trend in up-regulation of supernatant IL-6 and IL-8 levels, which were comparable to

Discussion

This is the first study to identify the mechanisms of S100A9-induced release of IL-6 and IL-8 from human PDL cells in vitro. Our results demonstrated that: (1) the functional receptor of S100A9 in human PDL cells is TLR4, but not RAGE; (2) S100A9 promotes the secretion of IL-6 through the NF-κB and p38 MAPK pathways; (3) S100A9 promotes the release of IL-8 via the NF-κB, ERK1/2, JNK1/2 and p38 MAPK pathways; and (4) ROS is involved in S100A9-mediated secretion of IL-6 and IL-8 from PDL cells.

Conclusion

Our study revealed that S100A9 promotes inflammatory cytokines expression of PDL cells through TLR4-mediated activation, but not RAGE. Additionally, our results revealed that the secretion of IL-6 and IL-8 from human PDL cells is through different signaling pathways and that the release of both cytokines depends on ROS production. Our findings build on the proposed mechanisms linking pro-inflammatoy S100A9 to autoimmune and inflammatory diseases.

Author contributions

HM and JH conceived and designed the experiments. HG, YZ, XZ, and LP performed the experiments. HG analyzed the data and wrote the paper.

Conflict of interests

The authors declare no conflicts of interests.

Acknowledgements

The authors appreciate Dr. Philippe A. Tessier (centre de recherche en Infectiologie, Centre de recherche du Centre Hospitalier Universitaire de Quebec, and Faculty of Medecine, Universite Laval, Quebec, Canada) for his kind gift of human S100A9 plasmids. This work was supported by the National Natural Science Foundation of China (30271411, 30471882, 30973319, 81271149).

References (44)

  • P.C. Chang et al.

    N-phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats

    J. Periodontol.

    (2014)
  • D.L. Cochran

    Inflammation and bone loss in periodontal disease

    J. Periodontol.

    (2008)
  • A. Di Benedetto et al.

    Periodontal disease: linking the primary inflammation to bone loss

    Clin. Dev. Immunol.

    (2013)
  • R. Donato et al.

    Functions of S100 proteins

    Curr. Mol. Med.

    (2013)
  • D. Foell et al.

    Mechanisms of disease: a ‘DAMP’ view of inflammatory arthritis

    Nat. Clin. Pract. Rheumatol.

    (2007)
  • S. Ghavami et al.

    S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

    J. Leukoc. Biol.

    (2008)
  • M. Hernandez et al.

    Host–pathogen interactions in progressive chronic periodontitis

    J. Dent. Res.

    (2011)
  • M. Ichikawa et al.

    S100A8/A9 activate key genes and pathways in colon tumor progression

    Mol. Cancer Res.

    (2011)
  • D. Jonsson et al.

    The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell

    J. Periodontal Res.

    (2011)
  • E. Kallberg et al.

    S100A9 interaction with TLR4 promotes tumor growth

    PLOS ONE

    (2012)
  • T. Kawai et al.

    The role of pattern-recognition receptors in innate immunity: update on toll-like receptors

    Nat. Immunol.

    (2010)
  • J. Kido et al.

    Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease

    J. Clin. Periodontol.

    (1999)
  • Cited by (39)

    • Orthodontic force-induced oxidative stress in the periodontal tissue and dental pulp elicits nociception via activation/sensitization of TRPA1 on nociceptive fibers

      2020, Free Radical Biology and Medicine
      Citation Excerpt :

      A recent in vitro study has reported that mechanical pressure and hypoxic conditions produce oxidants in human PDL fibroblast cells [25]. Oxidative stress is known to activate inflammatory mediator production through NF-κB signaling in PDL cells [26], in addition to osteoclast activation in bone remodeling [27,28]. Importantly, orthodontic force has been reported to cause hypoxia in the dental tooth pulp due to disturbance of blood circulation not only in the PDL tissue but also in the apical root region, leading to inflammatory responses inside the pulp in the ETM model [29].

    • Inhibition of the receptor for advanced glycation promotes proliferation and repair of human periodontal ligament fibroblasts in response to high glucose via the NF-κB signaling pathway

      2018, Archives of Oral Biology
      Citation Excerpt :

      Numerous studies have demonstrated that reactive oxygen species within the cells are released following RAGE and ligand binding (Daffu et al., 2013; Lee et al., 2010; Tan, Forbes, & Cooper, 2007). This leads to activation of canonical NF-κB signaling and regulation of the expression of important target genes, including various inflammatory factors such as TNF-α and interleukin-6 (IL-6) (Feng et al., 2013; Gao et al., 2015). In addition, TNF-α and IL-6 have been explored as diagnostic biomarkers for oral cancer (Sahibzada et al., 2017).

    • Evolutionary entrenchment in immune proteins selects against stabilizing mutations

      2022, Proceedings of the National Academy of Sciences of the United States of America
    View all citing articles on Scopus
    View full text